Cargando…
Effects of administration of basic fibroblast growth factor on hypoxic fractions in xenografted DLD-2 human tumours: time dependence.
A previous publication (Leith et al., 1992) showed that administration of basic fibroblast growth factor (FGF-2, 0.25 mg kg-1, q.i.d. x 7) to mice bearing xenografted DLD-2 human colon cancers would increase treated tumour growth rates as compared to control neoplasms. Additionally, at the end of th...
Autores principales: | Leith, J. T., Michelson, S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968615/ https://www.ncbi.nlm.nih.gov/pubmed/8398700 |
Ejemplares similares
-
Modification of the volumetric growth responses and steady-state hypoxic fractions of xenografted DLD-2 human colon carcinomas by administration of basic fibroblast growth factor or suramin.
por: Leith, J. T., et al.
Publicado: (1992) -
Comparison of basic fibroblast growth factor levels in clone A human colon cancer cells in vitro with levels in xenografted tumours.
por: McCarty, L. P., et al.
Publicado: (1995) -
Fraction of radiobiologically hypoxic cells in human melanoma xenografts measured by using single-cell survival, tumour growth delay and local tumour control as end points.
por: Rofstad, E. K., et al.
Publicado: (1998) -
Reducing the hypoxic fraction of a tumour model by growth in low glucose.
por: Hlatky, L., et al.
Publicado: (1989) -
Intracapillary HbO2 saturations in murine tumours and human tumour xenografts measured by cryospectrophotometry: relationship to tumour volume, tumour pH and fraction of radiobiologically hypoxic cells.
por: Rofstad, E. K., et al.
Publicado: (1988)